Solid Biosciences (SLDB) Cash & Current Investments (2017 - 2026)
Quarterly results put Cash & Current Investments at $380.7 million for Q1 2026, up 80.73% from a year ago — trailing twelve months through Mar 2026 was $380.7 million (up 80.73% YoY), and the annual figure for FY2025 was $187.8 million, up 134.12%.
Solid Biosciences has reported Cash & Current Investments over the past 10 years, most recently at $380.7 million for Q1 2026.
- Cash & Current Investments reached $380.7 million in Q1 2026 per SLDB's latest filing, up from $187.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $380.7 million in Q1 2026 and bottomed at $54.5 million in Q2 2022.
- Median Cash & Current Investments over the past 5 years was $185.5 million (2023), compared with a mean of $184.3 million.
- The largest annual shift saw Cash & Current Investments tumbled 72.82% in 2022 before it soared 193.67% in 2023.
- Over 5 years, Cash & Current Investments stood at $213.7 million in 2022, then tumbled by 42.15% to $123.6 million in 2023, then crashed by 35.11% to $80.2 million in 2024, then surged by 134.12% to $187.8 million in 2025, then soared by 102.65% to $380.7 million in 2026.
- Business Quant data shows Cash & Current Investments for SLDB at $380.7 million in Q1 2026, $187.8 million in Q4 2025, and $236.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 380.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380.68 Mn |
| Dec 31, 2025 | 187.85 Mn |
| Sep 30, 2025 | 236.14 Mn |
| Jun 30, 2025 | 268.11 Mn |
| Mar 31, 2025 | 210.63 Mn |
| Dec 31, 2024 | 80.24 Mn |
| Sep 30, 2024 | 171.12 Mn |
| Jun 30, 2024 | 190.27 Mn |
| Mar 31, 2024 | 206.07 Mn |
| Dec 31, 2023 | 123.64 Mn |
| Sep 30, 2023 | 142.88 Mn |
| Jun 30, 2023 | 160.19 Mn |
| Mar 31, 2023 | 185.51 Mn |
| Dec 31, 2022 | 213.72 Mn |
| Sep 30, 2022 | 142.16 Mn |
| Jun 30, 2022 | 54.55 Mn |
| Mar 31, 2022 | 180.05 Mn |
| Dec 31, 2021 | 207.78 Mn |
| Sep 30, 2021 | 109.77 Mn |
| Jun 30, 2021 | 200.70 Mn |
| Mar 31, 2021 | 268.50 Mn |
| Dec 31, 2020 | 155.07 Mn |
| Sep 30, 2020 | 24.80 Mn |
| Jun 30, 2020 | 40.77 Mn |
| Mar 31, 2020 | 53.91 Mn |
| Dec 31, 2019 | 83.52 Mn |
| Sep 30, 2019 | 105.99 Mn |
| Jun 30, 2019 | 67.71 Mn |
| Mar 31, 2019 | 95.07 Mn |
| Dec 31, 2018 | 122.46 Mn |
| Sep 30, 2018 | 145.61 Mn |
| Jun 30, 2018 | 146.06 Mn |
| Mar 31, 2018 | 165.14 Mn |
| Dec 31, 2017 | 52.21 Mn |
| Sep 30, 2017 | 15.08 Mn |
| Jun 30, 2017 | 32.72 Mn |
| Mar 31, 2017 | 29.27 Mn |